Title : Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Pub. Date : 2012 Apr

PMID : 22203325






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study. copolymer insulin Homo sapiens
2 METHODS: Development of protected graft copolymer (PGC) excipients that bind native human insulin non-covalently and testing blood glucose control obtained with these formulations in streptozotocin-induced diabetic Sprague Dawley rats compared to equally dosed insulin glargine. copolymer insulin Homo sapiens